Category: PRN Asia

Manhattan Associates Predicts Post COVID-19 Lockdown Retail Trends in Australia

SYDNEY, May 19, 2020 /PRNewswire/ — Manhattan Associates Inc. (NASDAQ: MANH) predicts five key business and technology trends that will have an impact on Australian retailers as they begin to reopen following the easing of COVID-19 restrictions.  Manhattan Associates Predicts Post COVID-19 Lockdown Retail Trends in Australia “The impact of COVID-19 on the Australian retail supply […]

Aetna International announces partnership with leading mental well-being app Wysa, as part of enhanced mental well-being support for members during COVID-19 pandemic

SINGAPORE, May 19, 2020 /PRNewswire/ — Aetna International has today announced that it is partnering with Wysa, a confidential and anonymous mental well-being app and service, as part of the company’s ongoing efforts to address the ‘second curve’ of the COVID-19 pandemic, the less visible but increasing mental well-being crisis. In response to members’ expanding mental […]

Excelra to Provide Lawrence Livermore National Laboratory With Small Molecule Medicinal Chemistry Intelligence Data to Help Develop Drug Design Platform

HYDERABAD, India, May 19, 2020 /PRNewswire/ — Under a three-year agreement, Excelra – a leading global data and analytics company – will provide Lawrence Livermore National Laboratory (LLNL) with GOSTAR, a small molecule medical chemistry intelligence database to aid drug design projects. The platform will support the aims of the Accelerating Therapeutics for Opportunities in Medicine […]

Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections

SHANGHAI and SAN FRANCISCO, May 19, 2020 /PRNewswire/ — Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced dosing of the first Chinese patient in the global ATTACK (Acinetobacter Treatment Trial Against Colistin) Phase 3 registrational trial evaluating the combination of sulbactam and durlobactam (SUL-DUR) for the treatment of carbapenem-resistant Acinetobacter […]

MediaOps Announces TechStrong Con: A Free 12-Hour Global Tech Conference Presenting Shared Experiences Of Resilience, Collaboration And Leadership To Overcome The Global Pandemic

Featuring more than 30 distinguished speakers across four tracks, including Emerging Technologies, Digital Transformation, Cyber/DevSecOps and Spotlight Solutions BOCA RATON, Fla., May 19, 2020 /PRNewswire/ — MediaOps today announces TechStrong Con, a free, 12-hour global tech conference focused on celebrating the tech community and its best practices during these extraordinary times. The virtual conference features thought […]

NCH Corporation Donates to Countries Affected by Covid-19 Through its Community Service Program, NCH Cares.

Donation from the Levy Family and NCH Corp. amounting US$60,000 was given to 4 Countries in Asia deeply affected by Covid-19: China, India, Malaysia and the Philippines. Beneficiaries are key institutions and frontliners devoted treating the pandemic in their countries SINGAPORE, May 19, 2020 /PRNewswire/ — NCH ASIA PACIFIC today announced the ongoing efforts of its […]

Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic

Exyte offers the new ExyCell® modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP). Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreactors, for low footprint and economic large-scale production of viral products. The combined offer enables users to rapidly deploy prefabricated GMP vaccine manufacturing […]

Back To Top